Histone/protein deacetylase inhibitors increase suppressive functions of human FOXP3+ Tregs.
about
Mucosal Interactions between Genetics, Diet, and Microbiome in Inflammatory Bowel DiseaseHistone deacetylase 6 plays a role as a distinct regulator of diverse cellular processesHDAC inhibitors and immunotherapy; a double edged sword?The Impact of Chemotherapy, Radiation and Epigenetic Modifiers in Cancer Cell Expression of Immune Inhibitory and Stimulatory Molecules and Anti-Tumor EfficacyA phase I trial of panobinostat (LBH589) in patients with metastatic melanoma.Epigenetic regulation of asthma and allergic disease.HDAC5 controls the functions of Foxp3(+) T-regulatory and CD8(+) T cellsRapid temporal control of Foxp3 protein degradation by sirtuin-1.Helios expression is a marker of T cell activation and proliferation.Epigenetic enzymes are the therapeutic targets for CD4(+)CD25(+/high)Foxp3(+) regulatory T cellsThe therapeutic potential of HDAC inhibitors in the treatment of multiple sclerosisHistone deacetylase inhibition regulates inflammation and enhances Tregs after allogeneic hematopoietic cell transplantation in humans.Histone deacetylase 6 and heat shock protein 90 control the functions of Foxp3(+) T-regulatory cellsHistone/protein deacetylases control Foxp3 expression and the heat shock response of T-regulatory cells.Histone deacetylase 9 deficiency protects against effector T cell-mediated systemic autoimmunityEssential role of mitochondrial energy metabolism in Foxp3⁺ T-regulatory cell function and allograft survival.Histone/protein deacetylases and T-cell immune responsesRegulation of immune responses by histone deacetylase inhibitorsDiffering effects of rapamycin or calcineurin inhibitor on T-regulatory cells in pediatric liver and kidney transplant recipientsButyrate increases IL-23 production by stimulated dendritic cells.Histone deacetylases 6 and 9 and sirtuin-1 control Foxp3+ regulatory T cell function through shared and isoform-specific mechanisms.The histone deacetylase inhibitor, romidepsin, suppresses cellular immune functions of cutaneous T-cell lymphoma patients.Targeting Sirtuin-1 prolongs murine renal allograft survival and function.The Effect of Latency Reversal Agents on Primary CD8+ T Cells: Implications for Shock and Kill Strategies for Human Immunodeficiency Virus Eradication.Anti-GD2 mAb and Vorinostat synergize in the treatment of neuroblastomaThe interplay of epigenetic therapy and immunity in locally recurrent or metastatic estrogen receptor-positive breast cancer: Correlative analysis of ENCORE 301, a randomized, placebo-controlled phase II trial of exemestane with or without entinostaClass I and II histone deacetylase inhibition by ITF2357 reduces SLE pathogenesis in vivo.HDAC inhibitors: modulating leukocyte differentiation, survival, proliferation and inflammation.Histone deacetylase inhibitors in the generation of the anti-tumour immune response.Epigenetic modulation with histone deacetylase inhibitors in combination with immunotherapy.The Effects of Tacrolimus on T-Cell Proliferation Are Short-Lived: A Pilot Analysis of Immune Function Testing.Histone deacetylase inhibitors as immunomodulators in cancer therapeutics.Understanding the Molecular Mechanisms of the Interplay Between Herbal Medicines and Gut Microbiota.Treg subsets in inflammatory bowel disease and colorectal carcinoma: Characteristics, role, and therapeutic targets.Epigenetic modifiers in immunotherapy: a focus on checkpoint inhibitors.HDAC6 is a Regulator of CTL Function through Control of Lytic Granule Dynamics.Understanding the epigenetic regulation of tumours and their microenvironments: opportunities and problems for epigenetic therapy.The nutrition-gut microbiome-physiology axis and allergic diseases.T cell signaling targets for enhancing regulatory or effector function.Standardization, Evaluation, and Area-Under-Curve Analysis of Human and Murine Treg Suppressive Function
P2860
Q26741117-75371929-C64C-40AB-89FC-34F93E16B389Q26830233-6F8853BE-A14F-4F45-8839-FDF9BD81BE81Q26853102-4A7DE5BE-23C3-4BC3-90C2-C8143DCC6CB5Q28076473-3EE0DDD5-4C44-486E-BE6D-A6CF4EAE6164Q33436058-D872F493-8463-4013-BC5D-62727445C680Q33755457-CB2290FF-8F67-4950-BAA8-D19F04F333ABQ33834432-60B53D35-3865-4632-9B41-E7D88A686A73Q33886284-DD191B7E-3FDD-425C-B9C1-A53035967A27Q34019821-83C4D98F-CA14-4B16-8F31-F2187CF2E54FQ34656908-F1D0DD88-0C84-460C-BCB0-B9B66C9DEA5DQ35016997-FC1C2663-8911-4EC9-A3C1-F10C6F38C815Q35029450-2C5F27FC-7B92-4BAB-B6E6-252B5F7D0BC2Q35096555-9BF4F124-4C1F-4E9C-819F-47156E236D18Q35300659-922F14E4-52DA-475A-835E-38AF4C6274F7Q35309505-BB96DF4C-EAAD-4598-A116-088690BF3477Q35660071-D856DA6E-B987-4708-9FB6-5E5C912CDB49Q35849307-6DA07F81-3BDD-45D9-8703-02D62F32AB1DQ35855571-C2BC0080-D9F6-4633-B247-AF209DEB02F8Q36442313-B4DF5F30-95AE-4A34-947F-8FEE005C3C2BQ36494684-C1158914-7D8C-4D4D-920B-E7E8DF776BB7Q36702713-38CED246-1A19-4815-83F4-A8B000687E2DQ36802272-490BCCD9-2591-4706-A2EF-8FA96D7A2D8DQ36805252-33FDF2B1-F4F5-4D47-BED7-16DFB8FE1B6BQ37034469-95D294E2-B41D-4C21-8BBD-4DEB46C86C6DQ37078946-5C1D3547-20E4-4F63-9263-F947219CA511Q37477372-8011CC5B-5194-4E6E-860B-D918A3C6A4B1Q37657613-3A3107BB-7869-4548-8D21-F6970AE78805Q37949185-18B23E66-9E31-4915-BDEF-1BF03AC452D4Q37953826-A79D9BDE-5F20-45F9-A6E5-F23859D82C47Q38537768-078F03B7-2D8B-4705-968E-4AF0D019C842Q38644612-685AB008-AB5A-4D6C-ADF2-B374714C76DFQ38763747-AC7FAFC8-7AF4-48D6-B0A1-EE906AE0B641Q38774900-D42F1F30-A3C9-4D29-8953-65C46A3DB3AEQ38779612-424A3AE2-8CDD-4301-A5CB-8717D4A1557CQ38838643-491C1452-CFD4-4FDF-B640-151B926F45E6Q38946427-415D2B76-D2BF-4014-B5BE-CAF9389340B7Q38988078-6A7736D5-6FE4-4320-A74F-664DE08649DAQ39402852-06188B84-FF3A-4084-8E41-A82B3ECC93A7Q39575774-E5F23868-01FA-44FA-B541-C2773A59F09CQ40360050-70C3E942-E37F-4A3E-A5B2-6A96E9851B5E
P2860
Histone/protein deacetylase inhibitors increase suppressive functions of human FOXP3+ Tregs.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Histone/protein deacetylase in ...... nctions of human FOXP3+ Tregs.
@ast
Histone/protein deacetylase in ...... nctions of human FOXP3+ Tregs.
@en
Histone/protein deacetylase in ...... nctions of human FOXP3+ Tregs.
@nl
type
label
Histone/protein deacetylase in ...... nctions of human FOXP3+ Tregs.
@ast
Histone/protein deacetylase in ...... nctions of human FOXP3+ Tregs.
@en
Histone/protein deacetylase in ...... nctions of human FOXP3+ Tregs.
@nl
prefLabel
Histone/protein deacetylase in ...... nctions of human FOXP3+ Tregs.
@ast
Histone/protein deacetylase in ...... nctions of human FOXP3+ Tregs.
@en
Histone/protein deacetylase in ...... nctions of human FOXP3+ Tregs.
@nl
P2093
P2860
P1433
P1476
Histone/protein deacetylase in ...... nctions of human FOXP3+ Tregs.
@en
P2093
Guanghui Ge
James L Riley
Liqing Wang
Tatiana Akimova
Tatiana Golovina
Tatiana Mikheeva
Wayne W Hancock
P2860
P304
P356
10.1016/J.CLIM.2010.04.018
P577
2010-05-15T00:00:00Z